Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Alzheimer Dis Assoc Disord. 1997:11 Suppl 3:39-45.

Authors

B Winblad¹, S Hill, B Beermann, S G Post, A Wimo

Affiliation

¹ Department of Geriatric Medicine, Karolinska Institute, Huddinge Hospital, Sweden.

PMID: 9305515

No abstract available

Publication types

Comparative Study

MeSH terms

Aged
Alzheimer Disease / drug therapy*
Alzheimer Disease / economics
Clinical Trials as Topic / economics
Cost-Benefit Analysis
Cross-Cultural Comparison
Dementia / drug therapy*
Dementia / economics
Drug Costs
Europe
Forecasting
Health Care Costs / trends
Humans
International Cooperation*
Nootropic Agents / economics*
Nootropic Agents / therapeutic use
Practice Guidelines as Topic
Treatment Outcome
United States

Substances

Nootropic Agents